Increase in atrial fibrillation-related mortality in the United States during the COVID-19 pandemic

Heart Rhythm. 2023 Feb;20(2):163-164. doi: 10.1016/j.hrthm.2022.09.012. Epub 2022 Sep 20.

Authors

Marco Zuin¹, Claudio Bilato²

Affiliations

¹ Department of Cardiology, West Vicenza Hospital, Arzignano, Italy; Department of Translational Medicine, University of Ferrara, Ferrara, Italy. Electronic address: zuinml@yahoo.it.
² Department of Cardiology, West Vicenza Hospital, Arzignano, Italy.

No abstract available

Keywords: Arrhythmias; Atrial fibrillation; COVID-19; Mortality; Pandemic.

Publication types

Letter

MeSH terms

Anti-Arrhythmia Agents / therapeutic use
Atrial Fibrillation* / drug therapy
COVID-19* / epidemiology
Humans
Pandemics
United States / epidemiology

Substances

Anti-Arrhythmia Agents